Boundless Bio, Inc. · NASDAQ:BOLD
Tang Kevin bought 107,463 Boundless Bio, Inc. shares (Form 4)
Traded Jun 30 to Jul 2, 2026 · Filed Jul 2, 2026
From Jun 30 to Jul 2, 2026, Tang Kevin (10% owner) bought 107,463 Boundless Bio, Inc. shares at an average US$2.50 for US$269K, leaving 2,641,308 shares. Filed Jul 2, 2026 (Form 4).
- Bought
- 107,463 shares
- Price
- US$2.50 average (US$2.49 to US$2.54)
- Value
- US$269K
- Holding after
- 2,641,308 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Buy | 25,930 | US$2.54 | 2,559,775 | Indirect |
| Jun 30, 2026 | Common Stock | Buy | 100 | US$2.50 | 2,559,875 | Indirect |
| Jul 1, 2026 | Common Stock | Buy | 71,612 | US$2.49 | 2,631,487 | Indirect |
| Jul 2, 2026 | Common Stock | Buy | 9,821 | US$2.49 | 2,641,308 | Indirect |
Source
Related
- Boundless Bio, Inc.
- Tang Kevin
- Boundless Bio, Inc. shareholders
- Form 4 · Tang Kevin · Oct 20, 2026
- Form 4 · Tang Kevin · Jul 21, 2026
- Form 4 · Tang Kevin · Jul 16, 2026
- Form 4 · Tang Kevin · Jul 13, 2026
- Form 4 · Tang Kevin · Jul 8, 2026
- Form 4 · Tang Capital Management LLC · Aug 28, 2026
- Schedule 13G · Zachary Hornby · Aug 27, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Form 4 · Gillis Steven · Jul 6, 2026